Home » Inspection of Pacira Plant Prompts EU Recall of Cancer Drug DepoCyte
Inspection of Pacira Plant Prompts EU Recall of Cancer Drug DepoCyte
September 10, 2012
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has urged Pacira Pharmaceuticals’ cancer drug DepoCyte be recalled in certain EU countries, citing “manufacturing deficiencies” found at the company’s San Diego, Calif., facility.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor